Trafalgar International, Inc. (GCAN)
Stock analysis · OTC · Healthcare · Medical - Pharmaceuticals
Trafalgar International, Inc. (GCAN) is a publicly traded company in the Healthcare sector. Latest price: $1.60. Market cap $318.20K. Trailing PE 0.36. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →You have viewed 4 SEO analysis pages
Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.
Continue with free signup1-Year Price
Proprietary Signals
About Trafalgar International, Inc.
Trafalgar International, Inc. focuses on acquiring, developing and growing businesses in the financial services, technology and intellectual property sectors. The company was formerly known as The Greater Cannabis Company, Inc. and changed its name to Trafalgar International, Inc. in July 2026. The company was founded in 2014 and is based in Miami, Florida.
Valuation
| P/E (TTM) | 0.36× |
|---|---|
| P/S (TTM) | 0.00× |
| P/B | -26.23× |
| PEG | 0.00× |
| P/FCF (TTM) | -7.82× |
| EV / EBITDA | -6.31× |
| EV / Sales | 0.00× |
| Earnings Yield | 276.55% |
| Free Cash Flow Yield | -12.79% |
Fundamentals
| Enterprise Value | $318.09K |
|---|---|
| Net Income (TTM) | $879.99K |
| Free Cash Flow (TTM) | -$209.43K |
| Net Debt | -$111.00 |
| Working Capital | -$12.13K |
| Gross Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
| Return on Equity | -133.43% |
| Return on Invested Capital | 1122.60% |
Peers
Recent News
Related
Browse more tickers: sitemap